Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kashani-Sabet, M.
Right arrow Articles by Miller, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kashani-Sabet, M.
Right arrow Articles by Miller, J. R., III
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
Journal of Clinical Oncology, Vol 20, Issue 7 (April), 2002: 1826-1831
© 2002 American Society for Clinical Oncology

Tumor Vascularity in the Prognostic Assessment of Primary Cutaneous Melanoma

By Mohammed Kashani-Sabet, Richard W. Sagebiel, Carlos M.M. Ferreira, Mehdi Nosrati, James R. Miller, III

From the Melanoma Center, Cutaneous Oncology Program, Cancer Center, University of California at San Francisco, San Francisco, CA.

Address reprint requests to Richard W. Sagebiel, MD, University of California at San Francisco Cancer Center, 1600 Divisadero St, Fourth Floor, San Francisco, CA 94115; email: moledoc{at}itsa.ucsf.edu

PURPOSE: The vascular supply of the primary tumor is recognized to play an important role in the progression of a number of solid tumors. However, the role of tumor vascularity in the prognostic assessment of melanoma remains unclear. The purpose of this study was to determine the prognostic impact of patterns of vascularity on the outcome associated with cutaneous melanoma.

PATIENTS AND METHODS: Tumor vascularity was documented prospectively using routine histopathologic analysis of 417 primary cutaneous melanomas from the University of California at San Francisco Melanoma Center database. Four patterns of tumor vascularity were recorded: absent, sparse, moderate, and prominent.

RESULTS: Increasing tumor vascularity significantly increased the risk of relapse and death associated with melanoma, corresponding to reduced relapse-free and overall survival. By multivariate analysis, tumor vascularity was the most important determinant of overall survival, surpassing tumor thickness. Increasing tumor vascularity was associated with increased incidence of ulceration in the primary tumor.

CONCLUSION: Tumor vascularity is an important prognostic factor in melanoma, rivaling tumor thickness. Increasing tumor vascularity is highly correlated with ulceration, possibly helping to explain the biologic basis of this known prognostic factor.

Presented in part at the Thirty-Seventh Annual Meeting of the American Society of Clinical Oncology, San Francisco, CA, May 12-15, 2001.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
M. Kashani-Sabet, S. Venna, M. Nosrati, J. Rangel, A. Sucker, F. Egberts, F. L. Baehner, J. Simko, S. P.L. Leong, C. Haqq, et al.
A Multimarker Prognostic Assay for Primary Cutaneous Melanoma
Clin. Cancer Res., November 15, 2009; 15(22): 6987 - 6992.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
J. F. Thompson, F. S. Hodi, and A. Zembowicz
Case 2-2007 -- A 49-Year-Old Woman with a Pigmented Lesion on the Arm
N. Engl. J. Med., January 18, 2007; 356(3): 285 - 292.
[Full Text] [PDF]


Home page
JCOHome page
J. Rangel, S. Torabian, L. Shaikh, M. Nosrati, F. L. Baehner, C. Haqq, S. P.L. Leong, J. R. Miller III, R. W. Sagebiel, and M. Kashani-Sabet
Prognostic Significance of Nuclear Receptor Coactivator-3 Overexpression in Primary Cutaneous Melanoma
J. Clin. Oncol., October 1, 2006; 24(28): 4565 - 4569.
[Abstract] [Full Text] [PDF]


Home page
Arch DermatolHome page
L. Shaikh, R. W. Sagebiel, C. M. M. Ferreira, M. Nosrati, J. R. Miller III, and M. Kashani-Sabet
The Role of Microsatellites as a Prognostic Factor in Primary Malignant Melanoma
Arch Dermatol, June 1, 2005; 141(6): 739 - 742.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
S. S.A. Qadri, J.-H. Wang, J. C. Coffey, M. Alam, A. O'Donnell, T. Aherne, and H. P. Redmond
Surgically Induced Accelerated Local and Distant Tumor Growth is Significantly Attenuated by Selective COX-2 Inhibition
Ann. Thorac. Surg., March 1, 2005; 79(3): 990 - 995.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
M. Kashani-Sabet, L. Shaikh, J. R. Miller III, M. Nosrati, C. M.M. Ferreira, R. J. Debs, and R. W. Sagebiel
NF-{kappa}B in the Vascular Progression of Melanoma
J. Clin. Oncol., February 15, 2004; 22(4): 617 - 623.
[Abstract] [Full Text] [PDF]



About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 2002 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online